The Valley Desk

NCT02921789 · Interventional trial

Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients

Overall registry status Completed

Phase 2

Conditions Kidney Transplantation, Primary Focal Segmental Glomerulosclerosis (FSGS)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov